ArticlePlant cell reports2026
Phytomelatonin receptor PMTR1 is crucial for melatonin-mediated plant broad-spectrum disease resistance.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
key messagePMTR1 is essential for melatonin-improved plant broad-spectrum disease resistance to bacterial pathogens and viruses. Melatonin plays vital roles in various plant stress responses, and the identification of phytomelatonin receptor 1 (PMTR1) in recent decades further extends the phytomelatonin signaling pathway. However, whether and how PMTR1 participates in plant broad-spectrum disease resistance has remained unclear. Here, we confirmed that exogenous melatonin enhanced disease resistance to bacterial blight and mosaic disease, indicating the crucial role of melatonin in cassava broad-spectrum disease resistance. In addition, the transcription of MePMTR1 was induced by Xanthomonas axonopodis pv. manihotis (Xam), common mosaic virus (CMV) and exogenous melatonin, suggesting that MePMTR1 may be involved in cassava immunity. Further investigation illustrated that MePMTR1 was a positive regulator in disease resistance to Xam and CMV, and it was necessary for melatonin-improved broad-spectrum disease resistance to the bacterial pathogen and the virus. Moreover, RNA-sequencing identified many differentially expressed genes (DEGs) in melatonin-improved disease resistance through MePMTR1, including calmodulin-like proteins (CMLs), calmodulin-binding proteins (CaMBPs), transcription factors WRKYs and MYBs, respiratory burst oxidase homolog protein C (RBOHC), heat shock protein 20, pathogenesis-related protein (PR10), etc. In total, this study provides new light on the theoretical foundation of melatonin in modulating broad-spectrum disease resistance in cassava, extending the understanding of the melatonin signaling pathway in plant immunity.
Indexed as
Identifiers
42029977What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.